Repair research
Most of BPC-157’s repair research is in cells or animals. The human reports below are much smaller than the claims you may have heard. We keep the setting beside each link so you know what you’re opening.
- The BPC-157 review describes the repair literature and the few published human pilot studies it covered in 2025.
- The blood-vessel study examines vessel growth and blood-flow recovery in lab and animal work, rather than injury recovery in people.
- The two-adult safety pilot reports an intravenous safety observation. It wasn’t a test of whether injuries healed better.
- The FDA’s BPC-157 review describes its makeup and examines the evidence available to the agency.
Retatrutide metabolic research
The explanation of how retatrutide works and the trials in people answer different questions. The trial results also concern different groups and measurements. They’re easier to follow when those pieces stay separate.
- The receptor study looks at how retatrutide interacts with GLP-1, GIP and glucagon receptors.
- The obesity trial reports weight change and side effects in the adults studied.
- The type 2 diabetes trial examines blood sugar and weight in adults with diabetes.
- The liver-fat trial measures liver fat in people with metabolic liver disease.
- The retatrutide review brings the early findings and unresolved safety questions together.
Tesamorelin’s particular use
For approval and safety, we use the prescribing information. The studies help explain the hormone signal and the clinical research. Each source has its own job.
- The hormone-response study examines the body’s growth-hormone response in healthy men.
- The longer abdominal-fat trial follows safety and effects in people with HIV and abdominal fat accumulation.
- The EGRIFTA WR tesamorelin label covers its approved use, follow-up findings, warnings and monitoring.
Access and FDA information
- The FDA’s compounding explanation explains why compounded medicines aren’t FDA-approved.
- The FDA’s safety-risk page includes BPC-157 in the nominated-but-withdrawn table. Withdrawal isn’t clearance. The page’s update date doesn’t tell us when an individual entry moved between tables.